In cases of skin cancer or cervical cancer with mixed viral genome status or episomal DNA [40,41], E2 together with Brd4 might switch from a repressive effect on the viral promoter on integrated genomes to an activating effect on the episomal genome as has been proposed before [42,43] with AP1 playing a prominent role. This evidence concerns the gene FOS and skin cancer.